289 related articles for article (PubMed ID: 29059162)
1. Activation of PPARα by clofibrate sensitizes pancreatic cancer cells to radiation through the Wnt/β-catenin pathway.
Xue J; Zhu W; Song J; Jiao Y; Luo J; Yu C; Zhou J; Wu J; Chen M; Ding WQ; Cao J; Zhang S
Oncogene; 2018 Feb; 37(7):953-962. PubMed ID: 29059162
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
[TBL] [Abstract][Full Text] [Related]
3. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.
Yu L; Li X; Li H; Chen H; Liu H
Tumour Biol; 2016 Oct; 37(10):13821-13829. PubMed ID: 27481517
[TBL] [Abstract][Full Text] [Related]
4. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
Bi YL; Min M; Shen W; Liu Y
Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
[TBL] [Abstract][Full Text] [Related]
5. GSK3beta and beta-catenin modulate radiation cytotoxicity in pancreatic cancer.
Watson RL; Spalding AC; Zielske SP; Morgan M; Kim AC; Bommer GT; Eldar-Finkelman H; Giordano T; Fearon ER; Hammer GD; Lawrence TS; Ben-Josef E
Neoplasia; 2010 May; 12(5):357-65. PubMed ID: 20454507
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer.
Tan Z; Zheng H; Liu X; Zhang W; Zhu J; Wu G; Cao L; Song J; Wu S; Song L; Li J
Oncotarget; 2016 Apr; 7(17):24076-87. PubMed ID: 26992223
[TBL] [Abstract][Full Text] [Related]
7. MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway.
Zhou W; Li Y; Gou S; Xiong J; Wu H; Wang C; Yan H; Liu T
Oncotarget; 2015 Nov; 6(35):37557-69. PubMed ID: 26485754
[TBL] [Abstract][Full Text] [Related]
8. Activating and Inhibitory Functions of WNT/β-Catenin in the Induction of Cytochromes P450 by Nuclear Receptors in HepaRG Cells.
Thomas M; Bayha C; Vetter S; Hofmann U; Schwarz M; Zanger UM; Braeuning A
Mol Pharmacol; 2015 Jun; 87(6):1013-20. PubMed ID: 25824487
[TBL] [Abstract][Full Text] [Related]
9. Targeting NEK2 impairs oncogenesis and radioresistance via inhibiting the Wnt1/β-catenin signaling pathway in cervical cancer.
Xu T; Zeng Y; Shi L; Yang Q; Chen Y; Wu G; Li G; Xu S
J Exp Clin Cancer Res; 2020 Sep; 39(1):183. PubMed ID: 32907622
[TBL] [Abstract][Full Text] [Related]
10. Activation of WNT/β-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61.
Sano M; Driscoll DR; DeJesus-Monge WE; Quattrochi B; Appleman VA; Ou J; Zhu LJ; Yoshida N; Yamazaki S; Takayama T; Sugitani M; Nemoto N; Klimstra DS; Lewis BC
Neoplasia; 2016 Dec; 18(12):785-794. PubMed ID: 27889647
[TBL] [Abstract][Full Text] [Related]
11. Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis.
Cheng R; Ding L; He X; Takahashi Y; Ma JX
Diabetes; 2016 Dec; 65(12):3730-3743. PubMed ID: 27543085
[TBL] [Abstract][Full Text] [Related]
12. Inflammation Promotes Progression of Pancreatic Cancer Through WNT/β-Catenin Pathway-Dependent Manner.
Ren R; Yu J; Zhang Y; Wang SF; Guo X; Shen M; Xu MD; Jiang M; Zhi Q; Chen K; Tao M; Wu MY; Gu DM; Li W
Pancreas; 2019 Sep; 48(8):1003-1014. PubMed ID: 31404031
[TBL] [Abstract][Full Text] [Related]
13. Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression.
Konduri S; Colon J; Baker CH; Safe S; Abbruzzese JL; Abudayyeh A; Basha MR; Abdelrahim M
Mol Cancer Ther; 2009 Mar; 8(3):533-42. PubMed ID: 19258429
[TBL] [Abstract][Full Text] [Related]
14. Widespread Repression of Gene Expression in Cancer by a Wnt/β-Catenin/MAPK Pathway.
Harmston N; Lim JYS; Arqués O; Palmer HG; Petretto E; Virshup DM; Madan B
Cancer Res; 2021 Jan; 81(2):464-475. PubMed ID: 33203702
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of the expression of Wnt5a promotes the proliferation of pancreatic cancer cells in vitro and in a nude mouse model.
Bo H; Gao L; Chen Y; Zhang J; Zhu M
Mol Med Rep; 2016 Feb; 13(2):1163-71. PubMed ID: 26648282
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of ANP32E is associated with poor prognosis of pancreatic cancer and promotes cell proliferation and migration through regulating β-catenin.
Zhang J; Lan Z; Qiu G; Ren H; Zhao Y; Gu Z; Li Z; Feng L; He J; Wang C
BMC Cancer; 2020 Nov; 20(1):1065. PubMed ID: 33148205
[TBL] [Abstract][Full Text] [Related]
17. In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier.
Hoque MT; Shah A; More V; Miller DS; Bendayan R
J Neurochem; 2015 Dec; 135(6):1113-22. PubMed ID: 26465636
[TBL] [Abstract][Full Text] [Related]
18. SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT-receptor complex.
Zhao SJ; Jiang YQ; Xu NW; Li Q; Zhang Q; Wang SY; Li J; Wang YH; Zhang YL; Jiang SH; Wang YJ; Huang YJ; Zhang XX; Tian GA; Zhang CC; Lv YY; Dai M; Liu F; Zhang R; Zhou D; Zhang ZG
Oncogene; 2018 Feb; 37(8):1049-1061. PubMed ID: 29084211
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.
Pramanik KC; Fofaria NM; Gupta P; Ranjan A; Kim SH; Srivastava SK
Oncotarget; 2015 May; 6(13):11561-74. PubMed ID: 25869100
[TBL] [Abstract][Full Text] [Related]
20. Clofibrate induces heme oxygenase 1 expression through a PPARα-independent mechanism in human cancer cells.
Wang S; Hannafon BN; Zhou J; Ding WQ
Cell Physiol Biochem; 2013; 32(5):1255-64. PubMed ID: 24247298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
